🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will test the hypothesis that MSCs in combination with Everolimu...
Status
Unknown
Location
Leiden University Medical Center
Start Date
2014-03
Trial ID
NCT02057965
Treatments Being Tested
This trial was designed to address important issues that impact recipients ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-01
Trial ID
NCT00622869
The immune system is the body's defense against infection and other disease...
Status
Completed
Location
Northwestern Memorial Hospital
Start Date
2013-02
Trial ID
NCT01653847
Treatments Being Tested
The reason for this extension is to evaluate the long-term safety and effic...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-03-31
Trial ID
NCT01150097
The aim of the present study is to evaluate the superiority of photopheresi...
Status
Unknown
Location
Deparment of Nephology and Kidney Transplant
Start Date
2022-08-17
Trial ID
NCT04414735
Treatments Being Tested
The purpose of this study was, starting from the Italian clinical practice ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-03-28
Trial ID
NCT02115113
Treatments Being Tested
Tacrolimus is a calcineurin inhibitor. This is the immunosuppression of ref...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02909335
Treatments Being Tested
The primary objective is to demonstrate the superiority of everolimus plus ...
Status
Unknown
Location
Hospital Universitário São José
Start Date
2011-08
Trial ID
NCT01399242
Treatments Being Tested
This study is examining the safety and efficacy of converting anti-rejectio...
Status
Completed
Location
University of California, San Francisco
Start Date
2012-09
Trial ID
NCT01624948
Treatments Being Tested
The purpose of this phase 3b study is to compare the safety and efficacy of...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-01
Trial ID
NCT01025817
Treatments Being Tested